Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Significant Insider Buying in CDTR.OB Lately.
http://www.secform4.com/insider-trading/1085113.htm
May be a sign of good things to come here.
Murocman
Significant Insider Buying in CDTR.OB Lately.
http://www.secform4.com/insider-trading/1085113.htm
May be a sign of good things to come here.
Murocman
Significant Insider Buying Lately.
http://www.secform4.com/insider-trading/1085113.htm
May be a sign of good things to come here.
Murocman
Since when is having to borrow money from a creditor in which you are already default to ever good news?!
I have to admit I was a shareholder here until the bottom started to fall out (sold at $0.07).
If the compahy is doing so well, how come they have to keep borrowing money? The 8-K that came out having them in default told me that this company is far from healthy and that operations are not increasing revenues to the point where the company will be self-sustaining, so I sold.
It's really too bad. I think this is great technology with a lot of potential, but I don't think Sequiam is going to be able to capitalize on the opportunity at the rate they are going.
All JMO. GLTU and all other holders.
Murocman
I'm betting we'll see earnings end of month.
Last year the company did not report annual earnings until 21 May. This was before they were fully reporting and re-listed on the OTCBB. Their last earnings report was on 15 Nov, which would have been the 45 day deadline for being in reporting compliance.
All that said, I think we'll probably see earnings for the year the end of March.
Who knows, we could get some other type of material announcement prior to that? All of the anecdotal stuff I have read indicates that credit/debit card use is exploding in China and South Asia. Hopefully this company will find a significant and profitable niche in that space?
GLTA,
Murocman
As my Grandmother so wisely said, "Almost" only counts in horseshoes and hand grenades.
Sorry for the poor humor...couldn't resist
GLTU
You can have them for $.07. The order is already in.
Update from EDS!
Inclement weather in the North East USA forced the cancellations of hundreds of airline flights.Unfortunately Friday investors meeting had to be cancelled, however this gives other investors and shareholders alike the opportunity to join AquaGold International & EricDavid & Sons in New York City for an exclusive investors meeting.If your interested in attending then please send an email to steveweiss@ericdavid.com I must hear from you no later then Wednesday March 12th for confirmation and will forward you the Day,Time and Place of the meeting. We must get this new meeting organized within the next 2 weeks as the CEO will be heading to China again in early April.
Regarding the name and symbol change, I spoke to MR. Manuel Da Silva and was advised that the NASDAQ automated systems are running a little behind but that he spoke with the administrator handling our case and that everything is in their system, so the name and ticker change shouldn't be much longer. The EDS IR department will give 24 hours notice of the name and symbol change in the form of a press release. AquaGold International along with EDS want to thank everyone for their patience during these delays.
Regards
Steve Weiss
Publisher
The EricDavid Newsletter
609-529-3671
Similar to previous post:
China's Electricity Council announced Friday that wind-generated power in China grew at a record rate last year, beating the 73% expansion from 2005 to 2006. This is one of the hottest sectors in alternative energy today, as evidenced by the proliferation of OTCBB companies scrambling to grab a piece of the pie. I want to add at least one of the following companies to the C.O.P. Index:
1) China Wind Energy (CWEY.OB): CWEY is an emerging company currently offering consulting and management services to wind energy operators in China. Its sole client is Lian Chuang in Harbin (in northern China), where it is helping with R&D, production and sales of wind turbine blade products. This contract with Lian Chuang will end in 2010.
2) China Wind Systems (CWSI.OB): CWSI is positioning itself to be a significant manufacturer of forged rolled rings and other components for the wind industry in China. For FY2007, the company anticipates revenues of $23 million and recurring net income of $3.6 million. For FY2008, the company is projecting revenues of $40 million and net income of approx. $7 million.
3) Welwind Energy [WWEI.OB]: WWEI is positioning to be a wind farm operator in China. Its first two projects are located in Yangxi and Zhanjiang in Guangdong Province, where it is currently doing feasibility studies. The company recently completed a $0.5 million financing to fund these projects, and already has a commitment from Guangdong Power to be connected to its grid.
China currently ranks fifth in the world in terms of wind power installed capacity (with 6.1 million KW), still far behind Germany, which is the top wind power producer with a total installed capacity of 20.6 million KW. However, China plans to increase its capacity to 10 million KW by 2015, and 30 million KW by 2020.
With energy consumption spiking, the Electricity Council has been instituting measures to support the growth of wind-generated power. These have included conducting survey of wind resources, organizing biddings for franchise of large wind power projects, and promoting localization of domestically produced wind power equipment. So far, these policies appear to be paying off.
Link:
http://seekingalpha.com/article/63946-2-wind-generated-power-companies-to-consider
Saw this one in my OTC News email letter. Definitely in a scary industry to invest in at the moment! If they can survive this may be great investment?
So why is it that everything (contract news, foreign investments, IR marketing, future growth plan, etc.) seems to be hanging on this stupid ticker symbol change.
The coporate structure of the company is what matters, and it looks to me like that has already been changed via Nevada and Florida SOS. The ticker of the stock should be irrelevant! The fact that it's not creates Red Flag in my mind. Further, the fact that it's taking so long adds more doubt. I have seen companies do this overnight per announcement, yet this company seems to have to make a soap opera drama out of every mundane corporate action.
For those invested, I say: be wary, be vigilant and don't fall in love. The opportunity of a lifetime comes along about every three weeks in the stock market (more often on the BB/Pinks if you're quick).
All JMO. If someone can logically refute my concerns, I'll happily admit I'm wrong.
GLTA
Murocman
Lots of potential here but this goes nowhere IMO until there is some concrete news that business activity is occurring. All of the previous PR's talk about the market potential and intentions but don't have any meat to them. I hope the people running this company realize that their window of opportunity will never be better than it is now.
Let's get on with it already! Talk is cheap!
GLTA,
John
Anybody have an idea when 4Q/Annual Earnings will be out?
I noticed that the report last year was not filed until May. I'd hope that they would be a lot more timely this time around, like before 31 March.
TIA/GLTA
John
FYI here is Aquagold's CUSIP Number from the CUSIP service Bureau:
Main Information
Issuer Name (Long) ISIN Issue Description CUSIP/CINS
AQUAGOLD INTL INC US03841Q1094 COM 03841Q109
FYI...NASDAQ assigns all pinksheet stocks per link below:
http://www.pinksheets.com/pink/faq.jsp#6a
Just got the following from EDS:
Dear Readers,
Ok I admit it took an additional 48 to 72 hours longer then I thought.Thanks for all the emails and phone calls this past week, I got to meet and speak with many new investors from all over the World.
The ticker and name change to Aquagold International will be automatic as per the Press Release.
AQUAGOLD International, Inc. (OTC: ONMC) Announces That the Official CUSIP and Name Changes Have Been Filed With State of Nevada and NASDAQ
OMNINETMEDIA.COM Name Change to AQUAGOLD International, Inc. and CUSIP Change Completed
LAS VEGAS, NV and MONTREAL--(Marketwire - February 22, 2008) - Manuel Da Silva, CEO of AQUAGOLD International, Inc. (PINKSHEETS: ONMC) announced today that OMNINETMEDIA.COM (PINKSHEETS: ONMC) name and CUSIP change from OMNINETMEDIA.COM to AQUAGOLD International, Inc. has been completed and will be effective within 10 business days. "At that time NASDAQ will also assign the new trading symbol which will be announced as soon as we receive it. Today our Transfer Agent has completed and filed for our new CUSIP and has also filed his TA-1 Form officially notifying NASDAQ of our new official corporate name AQUAGOLD International, Inc. and our new CUSIP number. Further, all State of Nevada filings have already been updated to reflect these changes," Mr. Da Silva stated.
About AQUAGOLD International, Inc.
"AQUAGOLD" branded premium Canadian Spring Water is presently being shipped into China. In 2005, sales of bottled water in China experienced strong growth of 16% (liters) and 15% (RMB/$) to reach 11.2 billion liters and RMB24.1 billion or $3.17 Billion USD in volume and current value terms. The estimates on AQUAGOLD'S China contract alone exceed $500 Million in revenues, however how much in excess will follow in the near future resulting from ongoing marketing activities such as the upcoming trade show in Shanghai, China over the coming few weeks.
AQUAGOLD is actively pursuing additional growth and is focused on growing market share in China as well as the rest of Asia, and the Company anticipates even more substantial opportunities in the near future as the Chinese capital city of Beijing hosts the 2008 Olympic Summer Games.
About EricDavid & Sons, Inc.
Specializing in investor relations, EricDavid & Sons, Inc. is a financial management, marketing and consulting firm that retains as clients only those who are perceived to offer unusual products or services with the potential to command a dominant position in their respective industry/marketplace and publicize companies with unique products services offerings whose stock is undervalued in relation to their long-term earnings potential.
Forward-Looking Statements
This news release contains forward-looking statements made by OMNINETMEDIA.COM, INC. in reliance upon the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All such statements included in this press release, other than statements of historical fact, are forward-looking statements. Although Management believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. Actual results may differ materially from those indicated by these statements. The following risk factors, among others, could cause actual results to differ materially from those described in any forward-looking statements. These risks and uncertainties include, but are not limited to, economic conditions, changes in the law or regulations, demand for products and services of the company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward-looking statements. Forward-looking statements are typically identified by the words: believe, expect, anticipate, intend, estimate, and similar expressions or which by their nature refer to future events.
Please view the disclaimer for ONMC here
http://www.ericdavid.com/newsletter/disclaimer/ONMC.htm
-------------------------------------------------------------------------
To be removed from this mailing list
click on the link below
http://www.ericdavid.com/cgi-bin/list/mail.cgi?johnandi@msn.com
Markets are closed Monday for Presidents Day
If the hype lives up to expectations and the newsletter is followed by some solid PR's, I definitely agree with you. I wouldn't be surprised to see us hit $0.25-0.30 somehwere during the week.
JMO, GLTA!
John
$0.10 share price gives this a market cap just below $75M
Whether or not the price gets there will have everything to do with the size of the initial contracts signed IMO. I think we'll need to have double-digit million dollars sales pojections before this sees $0.10 and stays there. If it does happen to get there in the short term, I'll probably take profits and look for a lower price to get back in.
GLTA,
John
It might, but there isn't much correlation between how pinksheet/OTCBB stocks move and the rest of the market. The main reason is that institutions drive approximately 3/4 of the volume on the broad markets while the pinks and OTCBB are almost exclusively retail. This stock will be driven much more by the pending news and optimism surrounding it, rather than the overall market. If your a believer, I'd advise you get it tomorrow with the expectation you'll have a nice gain on your hands in a week.
THERE YOU GO AGAIN...to quote Ronald Reagan. If you would have chosen to post the whole article you would have noticed that the company expects "significant top lines sales in 2008" from new products including SMARTSCAN Biometric locks!
From news release:
Kwikset® Corporation's facility in Denison, Texas recently announced to employees that it will implement a two-week holiday shutdown in manufacturing operations from December 17, 2007 until January 2, 2008. Over the past year, the decline in the US housing market, uncertainty in the mortgage and credit industries, a significant slow down in the US economic growth rate, and a resulting weakening in consumer confidence have led to a reduction in sales estimates. The shut down will allow the Company to better align inventory levels with 2008 production requirements. The Company will implement a concurrent shut down in its Mexicali manufacturing facility.
Kwikset expects to drive significant top-line sales in 2008 with two new product launches - K2TM and SmartSeriesTM. K2 is the Company's new commercial line that features a collection of stylish industrial door hardware solutions that includes cylindrical and tubular levers, deadbolts, door closers and exit devices. The SmartSeries platform includes SmartKeyTM with BumpGuardTM features, the Company's patented, revolutionary new technology that allows homeowners to re-key their own locks in seconds while maintaining the highest level of security, SmartScanTM, the first biometric scanning residential deadbolt on the market, and SmartCodeTM, personalized touchpad keyless entry deadbolt.
The Denison plant is part of Black & Decker® Hardware and Home Improvement Group (HHI) that includes door hardware by Kwikset - Trusted Name in Security for over 60 years, Baldwin® Hardware, Weiser Lock®, K2 Commercial Hardware, and Price Pfister® plumbing fixtures and accessories. The Denison facility produces components for Kwikset door locks and other Black & Decker products.
Since when is a 210M Public Float low? 2.1M shares....now that would be a low float. If look at stocks that have been big winners, they typically do not have floats approaching anywhere near 100M shares when they made their biggest advances.
I'm not saying there isn't money to be made trading this stoc, but I wouldn't be holding out for $0.10 as I think you will be sorely disappointed. Just my two cents and some food for thought.
In the spirit of full disclosure. If you go to the Home Depot site you will find three product reviews for the Kwiset Biometric dead bolts. TWO are positive reviews and one is the negative review posted here.
GLTA
Trying to find a reason to hold this stock. The article at the following link is positive on RFID in the pharma industry. Hopefully Traxxec will benefit via Rexam?
http://www.healthcare-packaging.com/archives/2007/12/healthy_prognosis_for_healthca.php#more
December 25, 2007
Healthy prognosis for healthcare packaging
Subscribe For Free!
Sign up to receive the weekly e-mail newsletter and quarterly print publication. Learn more >
Pharmaceutical firms seek packaging line improvements to cut costs, biologics present packaging challenges, and medical device growth is driven by aging baby boomers. These treatment advances bode well for the healthcare/life sciences packaging community. Packaging materials need to offer protection from point of manufacture to the “last mile” where healthcare products reach a patient. Packaging materials must provide barriers for moisture, oxygen, light and heat, and they may include overt and/or covert security measures to combat counterfeiting and diversion. Equipment will need to package products more efficiently, be validatable and versatile.
All of this will require people power. “It’s been reported that three of eight jobs in the next 20 years will be in the healthcare field,” says Gerald Finken, president and founder of CSM, a company that provides packaging and labeling services for clinical trials.
Despite this good news, healthcare packagers continue to face daunting challenges, such as satisfying Food and Drug Administration and regulatory demands. Eric Greenberg, attorney-at-law and Packaging World and Healthcare Packaging columnist, provides the following example: “In the FDA Amendments Act of 2007 is a little-noticed section, 913, that adds a new section to the law called ‘pharmaceutical security’ that calls for federal government officials to ‘develop standards and validate effective technologies’ to secure the drug supply chain against ‘counterfeit, diverted, subpotent, substandard, adulterated, misbranded, or expired drugs.’
“A new law that was widely described as strengthening FDA powers over approved drugs contains a spotlight on packaging that, among other things, will soon require unique numbering of individual packages of prescription drug products.” Within the next 21⁄2 years, he says, “the FDA will have to create a system of standardized numerical identifiers for prescription drugs to be applied ‘at the point of manufacturing and repackaging...at the package or pallet level.’ These numbers will allow identification, validation, etc., of the product.”
Beyond legal and regulatory matters, this healthcare packaging forecast also explores a handful of “hot-button” issues and trends. The article will also look at developments and forecasts in pharmaceutical, biologic, and medical device packaging.
Healthcare packaging issues and trends
Sustainability. With so many demands already placed on a pharmaceutical or medical device package, does the package have to be earth-friendly as well? Yes, says Michael Rubenstein, president of Alcan Global Pharmaceutical Packaging. Alcan representatives report that many of their customers are clamoring for more information on this topic.
Innovation and package design. Understandably, manufacturers in the healthcare community allot significant financial resources to product research and development. Sometimes, that means package design innovation is viewed as a luxury. However, developments in drug delivery devices such as inhalers, patches, stick packs, and Target’s prescription drug bottles exemplify innovation. So, too, do package designs for GlaxoSmithKline’s alli starter kits, Barr Pharmaceutical’s oral contraceptive, and VasoActive Pharmaceutical’s over-the-counter topical lotions, as reported by Shelf Impact! editor Jim George.
George says, “The marketing value of packaging is a largely untapped frontier in over-the-counter pharmaceuticals. Packages delivering cognitive value can support a great product—and drive sales.” When justifying financial investments in package design, George asks, “What is the cost if the packaging for your healthcare product remains purely functional and ignores aesthetics? Consider that if you do nothing, your competitors may well be doing something—and gaining an edge in the battle for shelf supremacy.”
RFID gains. Although the use of radio-frequency identification is in its early stages, “RFID holds great potential for the healthcare industry, and the adoption of the technology is expected to increase significantly owing to the benefits it offers.” That’s according to RFID Opportunities in Healthcare in the U.S., a new $3,900 market-research report from Kalorama.
This year, the RFID market in the U.S. healthcare industry is estimated to be about $297 million, says the report. By 2012, the market’s value is forecast to be $3.1 billion. The report’s executive summary says, “Hospitals are expected to be the frontrunners in terms of investment in RFID technology. Moreover, the adoption of RFID by hospitals in the U.S. was estimated to be 10 percent in 2005 and is expected to increase to 80 percent by 2011.”
Robotics. Watch for pharmaceutical firms to increase their use of robotics, from processing through packaging functions (as seen in this article's photo, supplied by ABB Robotics). AstraZeneca, for example, employs robotics on several of its packaging lines at its plant in Södertälje, Sweden. The company’s use of robotics is likely to continue, according to Lars Siggelin, senior project manager of AstraZeneca’s Global Technical Services. “High flexibility and ‘digital’ changeover,” are among the benefits he sees with robotic packaging. “They’re also more ergonomic, requiring no [manual] lifting or handling of boxes.” He says robotic equipment can be economically justified in that robots are the same price as ‘common’ machines, but have better and more flexible functions. “Robots can be used for other purposes, as they are very general equipment,” he adds.
Automation standards. Dr. Ken Ryan, director of the Center for Automation in Motion Control at Alexandria Technical College, and Shane Loughlin, president of SL Controls , were recently in Ireland investigating a healthcare packaging-related application with a biomedical manufacturer that preferred not to be identified. The application leveraged automation standards to integrate “best-of-breed” equipment.
Ryan and Loughlin were involved in the OMAC Users Group , a nonprofit organization dedicated to the development and use of open, interoperable control and automation systems technologies for end users, technology providers, and OEMs.
At press time, a new group of pharmaceutical manufacturers, automation companies, and equipment suppliers was in the process of forming to collaborate in developing automation strategies to improve the effectiveness and value of machinery used in the healthcare/life sciences industry. Further details about this group were not yet available.
Pharmaceutical packaging
For years, pharmaceutical products have typically enjoyed healthier profit margins than those of food and beverages, so maximizing packaging line efficiency wasn’t urgent. But as drug patents expire, and less-expensive generic drugs enter the market, this is driving down prices and margins. So it’s understandable why drug manufacturers want to wring out more efficiencies from their packaging lines by employing processes such as Six Sigma, lean manufacturing, and/or Overall Equipment Effectiveness.
Looking at the global pharmaceutical market, developed countries in Western Europe, the United States, and Japan will account for nearly three-fourths of the demand for worldwide pharmaceutical packaging, according to The Freedonia Group. Freedonia projected this demand to increase 5.9% per year to more than $34 billion in 2011 in its new study, World Pharmaceutical Packaging.
Freedonia forecasted that China will provide the strongest growth opportunities, while India and Brazil “will evolve into fast-growing pharmaceutical packaging markets as drug-producing sectors are upgraded and diversified,” especially generic drugs. Among other findings in the report were the following:
• Easing government-imposed drug price controls and export growth will boost pharmaceutical packaging sales in Japan.
• Prefillable inhalers and prefillable syringes will generate opportunities based on benefits in drug delivery and the introduction of bioengineered medicines. These will help increase global demand for primary pharmaceutical containers 6.5% annually through 2011 to nearly $24 billion.
• The world market for pharmaceutical closures and accessories will grow 4.5% per year to $10.6 billion in 2011, with the largest gains in child-resistant, senior-friendly, and dispensing closures.
The 515-page report is available from The Freedonia Group for $5,800 by e-mailing pr@freedoniagroup.com.
Biologics packaging
Biologics-based products and combination products appeal to some pharmaceutical firms, for their treatment potential, their financial prospects, and their ability to extend patent protection. “There is a lot more patent protection around these [biologics] molecules,” says Robert Smith, a director at Genzyme in the U.K. “Proteins and biologics are larger molecules than typical drugs.
“The packaging of these products relates to the sensitivities of these proteins, which are also less robust than chemical molecules. And these products have to be frozen or lyophylized [freeze-dried] for a shelf life that’s useful in a commercial sense.” Even then, Smith estimates the shelf life of biologics is typically 12 to 18 months, compared to years for pharmaceutical tablets.
Looking into his crystal ball, the Genzyme professional believes packaging material developments may help extend the shelf life of biologics. “Glass vials have been around for a long time, and I think things like polypropylene and other materials could come into play for biologics.” He also envisions advances in blow/fill/seal technology that could be extended into this field.
Smith says biologics are typically manufactured under aseptic conditions. Developing processes to extend shelf life, he believes, will be an important packaging challenge. And then there’s validation. “Process validation of biologics is probably a more stringent process than for drugs or medical devices,” he believes. He refers not only to the packaging process, but also to operator qualification—demonstrating that they can work in an aseptic environment. “There is some qualification of personnel in all sorts of sterile manufacturing, where you actually qualify the individual to make sure that they are not contaminating the product,” says Smith.
The Center for Biologics Evaluation and Research (CBER) is the center within the FDA that regulates biological products. Its Web site says these products include “vaccines, blood and blood components, somatic cells, gene therapy, tissues, and recombinant therapeutic proteins. In contrast to most drugs that are chemically synthesized and have a known structure, most biologics are complex mixtures that are not easily identified or characterized.
“Biological products, including those manufactured by biotechnology, tend to be heat-sensitive and susceptible to microbial contamination,” the Web site continues. “Therefore, it is necessary to use aseptic principles from initial manufacturing steps, which is also in contrast to most conventional drugs.”
The CBER Web site adds, “Biological products often represent the cutting edge of biomedical research and, in time, may offer the most effective means to treat a variety of medical illnesses and conditions that presently have no other treatments available.”
“With the rapid growth in the biopharmaceutical industry over the past two decades, the number of newly approved biological products has dramatically increased,” says the Intl. Society for Pharmaceutical Engineering , a global not-for-profit society of pharmaceutical manufacturing professionals representing some 25,000 members in 90 countries. “In 2005, a record 21 biological products received U.S. Food and Drug Administration approvals, including therapies for the treatment of rheumatoid arthritis, diabetes, cancer, and rare genetic disorders.”
CSM’s Finken offers this input concerning the promise of biologics: “I think it’s about mankind wanting to find the magic bullet.” He adds that one of the challenges in packaging biologics “is that you are dealing with frozen product. If you let it thaw, the potency will drop.” He says biologics are expensive to produce “because the process may involve 30 or 40 steps done in sterile or near-sterile conditions. You can’t heat the product, and many times handling involves keeping the product in liquid nitrogen.”
Medical device packaging
According to Urmila Kishore, “Continuous technological advancements in the medical device market coupled with an aging population provides wide opportunities for growth in the medical device packaging market.” Kishore is the analyst of the study The North American Medical Device Packaging Market from Frost & Sullivan .
The study shows that the market earned revenues of $569 million last year, with that number predicted to rise to $918.8 million by 2013. Among the report’s findings are the following:
• Packaging is an integrated and vital component in the medical device market. The North American medical device packaging market is experiencing steady growth. Despite the growth, this market is also expected to face stiff competition due to the cost-reduction pressure created by device manufacturers.
• The scientific and technological breakthroughs to improve health and lengthen the average life span have accelerated the pace of medical invention, resulting in a plethora of new medical devices with advanced features and superior performance properties. Package manufacturers are encouraged to respond to new product requirements by employing advanced technologies and materials.
• Disposable medical devices, including surgical supplies, are extremely popular. “This market is expected to grow at the rate of 23-percent through 2011, as increases in the number of surgeries have heightened the concern over postoperative infection,” explains Kishore. “The demand for implants is anticipated to encourage the use of rigid packaging materials such as trays, which is likely to boost the revenues of rigid packagers.”
• Medical device packagers face a challenge in coping with emerging trends. Says Kishore, “The introduction of combinational drug delivery devices is posing a major challenge to packagers to come up with new, innovative packaging that suits the products.”
--By Jim Butschli, Editor
I have to disagree with you there.
For anyone who happens to be a student of William O'Neill and CANSLIM investing, the BZP chart looks like almost a perfect "W" base pattern which is very bullish. There are a couple different ways to play this base pattern using CANSLIM investing principles (see *ww.investors.com for details in the stock philosophy)
Notice the "W" shape of the base, and the fact that the low price on the right half of the "W" is very similar to the right half ($11.70 vice $11.05). Ideally you'd see the low on the right half a tad bit below the left half, but not a big deal. The symmetry provides so solid price support. If you look at a dailay chart you'll also notice some sideways movement on lower volume the last few days as the stock has approached and made new highs. This represent resistance in the form of folks who bought at previous highs selling out because they fear the stock may go back down. While I do agree that this pattern coud represent a top, the fact that the volume is decreasing on a daily basis as the stock moves sideways, indicates to me that the selling is drying up and the stock will likely make its next major move higher rather than lower.
Now the buying strategy:
Normally the pivot, or buy point of a "W" base is when the stock price passes the high point set in the middle of the base. For this stock that would have been $13. The exception/ammendment to that rule is that if the base forms a "handle" on the right side, the buy point reached when the price passes the high of that handle on heavy volume. For this stock the high of the handle is $13.38 and was set on Thursday as the stock pulled back on low volume.
You can read lots more on this base pattern at www.investors.com.
Bottom line, the technicals and fundamentals look excellent for this stock. It is in the right sector at the right time with growing fundamentals. I'd be a buyer at these levels and all the way up to $14 per share.
GLTA,
John
Old O/S count from Feb 2006 FWIW:
808M
http://www.pinksheets.com/pink/quote/quote.jsp?symbol=insn
John
A post ( or probably re-post) of some of the fundamentals and market prospects surrounding RFID in Pharmaceutical packaging:
http://www.rfidupdate.com/articles/index.php?id=1472
http://www.rfidupdate.com/articles/index.php?id=1473
GLTA
John
Date on transalted article is 30 March 07. This isn't really anything "new" The article at the link below alludes to the fact that they have already been producing bottles:
http://www.pinksheets.com/pink/quote/quote.jsp?symbol=crvv
Looks like it may have potential. It would be nice to see them move towards becoming a reporting company in order to legitimize the business and garner more investment.
GLTA,
John
I believe the last filing I read stated they had gotten a couple different loans (rate was 5% if I recall) to construct the facility.
John
This stock made a nice move today. In a hot sector and bringing capacity online at the right time, it appears? Between that and the sector hype, I have a target of $4 by 1 May if factory comes online and orders materialize. Anybody else have any thoughts?
John
10Q out - not very pretty.....
http://biz.yahoo.com/e/080103/tofs.pk10qsb_a.html
I don't see Sequiam on the exhibitor list, so unless their customers are out showing off product, I wouldn't expect too much.
John
Found this while doing some DD on Thorium Nuclear Power
India looks at thorium for nuclear power
Written on November 22, 2007 – 5:30 pm | by FIDSNS | India has formulated a three stage nuclear power programme to optimally use its modest uranium and vast thorium resources to fulfill the increasing energy requirements of the country. Large scale thorium utilization is contemplated in the third stage of this programme, where uranium – 233 bred in fast breeder reactors of the second stage, will be used together with thorium. The Government has taken a number of steps to develop appropriate technologies for the utilization of thorium. A few of the major steps are :
1. Setting up the research reactor Kamini at Kalpakkam using uranium-233 fuel obtained from irradiated thorium. The reactor has been operating since 1997. The fuel for the reactor is bred, reprocessed and fabricated indigenously.
2. Irradiation of thorium fuel bundles in research reactor at Trombay and in Pressurized Heavy Water Reactors (PHWRs).
3. Design and development of Advanced Heavy Water Reactor (AHWR) using thorium based fuel. Pre-licensing safety review of AHWR has been completed by Atomic Energy Regulatory Board (AERB).
4. India has developed technologies to reprocess irradiated thorium fuel and in fabricating uranium-233 based fuel.
Throrium in India is mainly recovered from a naturally occurring mineral – monazite. Monazite is produced as a co-product alongwith ilmenite, zircon, rutile, etc. A quantum of Thorium in the form of thorium concentrate is produced as a by-product of rare earth compounds which are recovered from monazite. 30,000(thirty thousand) tones of such thorium concentrate is stored in silos for future use.
Dec 27, 2007 05:05 ET
Chinese, U.S. Firms Sign Deal for Large Windfarms, an Industrial Info News Alert
Highlighted Links
Industrial Info Resources
BEIJING--(Marketwire - December 27, 2007) - Researched by Industrial Info Resources (Sugar Land, Texas) -- Guangdong Mingyang Wind Power Technology Company Limited, a subsidiary of Guangdong Mingyang Electric Group Company Limited, signed a contract with GreenHunter Energy Incorporated, a well-known U.S. wind power operator, in late November for 72 sets of 1.5-megawatt (MW) cold-weather wind turbines to New York, the Mingyang Electric Group announced.
For details, view the entire article by subscribing to Industrial Info's Premium Industry News at http://www.industrialinfo.com/showNews.jsp?newsitemID=125658, or browse other breaking industrial news stories at www.industrialinfo.com.
Industrial Info Resources (IIR) is the leading marketing information services company for the industrial process, heavy manufacturing and energy-related markets throughout the world. Celebrating its 25th anniversary, IIR provides accurate and timely intelligence featuring plant and project information databases, focused market databases, industry forecasting, key industry contacts, industry and territorial map products, direct marketing services and applications, and daily industry news. For more information send inquiries to powergroup@industrialinfo.com or visit us online at www.industrialinfo.com.
I wonder if Welwind is involved at all in this?
I'm kind of surprised we haven't heard anything of the PPA. Maybe negotiations are taking longer than expected? If we don't here anything by the 28th, I'll be a little concerned.
GLTA,
John
Inova Technology (ITVH.PK) closes acquistion.
Form 8-K for INOVA TECHNOLOGY INC.
--------------------------------------------------------------------------------
21-Dec-2007
Completion of Acquisition or Disposition of Assets
Item 2.01 Completion of Acquisition or Disposition of Assets.
Inova closes acquisition of Desert Communications
Inova has signed a definitive agreement to acquire Texas based Desert Communications ("Desert") for $5.5 million. The acquisition closed on December 21, 2007.
For the year ending December 2006, Desert generated revenue of $13 million and ebitda of $1.8 million. Inova will pay $3.2 million cash on closing and a $2.3 million note payable over three years.
Funding for the acquisition was obtained from IBM and Boone Opportunity Lenders ("Boone"). IBM provided a $2.5 million line of credit and Boone Opportunity Lenders provided a $2 million debenture. Southbase LLC (a company related to the CEO, Mr Adam Radly) has also agreed to convert $600,000 of cash invested into Inova since December 2006 into stock of the Company in order to improve the Company's balance sheet.
The sellers of Desert will not be receiving Inova stock as part of the transaction. Boone will be entitled to receive shares in Inova equal to approximately 13% of the fully diluted common stock of the Company. Therefore the transaction is EPS positive (earnings per share positive) for all shareholders.
Following these transactions the total common stock outstanding (on a fully diluted basis) of the Company will be approximately 1,200,000,000. Based on a share price of $0.01 the market capitalization of the Company would be approximately $12 million.
Desert provides IT services to a customer base that primarily consists of Texas based school districts, local government entities and corporations. Services provided by Desert include IT network and communications services, network design, implementation and maintenance. Inova and Desert have been developing three RFID pilots together for schools, libraries and prisons.
Inova is also assessing additional acquisition opportunities and is targeting businesses that offer RFID solutions or can assist Inova to enhance its current suite of RFID solutions or can accelerate the roll out of Inova RFID solutions.
(b)Exhibits*.
Exhibit No. Item
1 Press Release.
* Pursuant to Item 601(b)(2) of Regulation S-K, certain of the exhibits and schedules may have been omitted. If so, such exhibits and schedules will be provided to the Securities and Exchange Commission upon request.
Desert Communications Acquisition closed!
Form 8-K for INOVA TECHNOLOGY INC.
--------------------------------------------------------------------------------
21-Dec-2007
Completion of Acquisition or Disposition of Assets
Item 2.01 Completion of Acquisition or Disposition of Assets.
Inova closes acquisition of Desert Communications
Inova has signed a definitive agreement to acquire Texas based Desert Communications ("Desert") for $5.5 million. The acquisition closed on December 21, 2007.
For the year ending December 2006, Desert generated revenue of $13 million and ebitda of $1.8 million. Inova will pay $3.2 million cash on closing and a $2.3 million note payable over three years.
Funding for the acquisition was obtained from IBM and Boone Opportunity Lenders ("Boone"). IBM provided a $2.5 million line of credit and Boone Opportunity Lenders provided a $2 million debenture. Southbase LLC (a company related to the CEO, Mr Adam Radly) has also agreed to convert $600,000 of cash invested into Inova since December 2006 into stock of the Company in order to improve the Company's balance sheet.
The sellers of Desert will not be receiving Inova stock as part of the transaction. Boone will be entitled to receive shares in Inova equal to approximately 13% of the fully diluted common stock of the Company. Therefore the transaction is EPS positive (earnings per share positive) for all shareholders.
Following these transactions the total common stock outstanding (on a fully diluted basis) of the Company will be approximately 1,200,000,000. Based on a share price of $0.01 the market capitalization of the Company would be approximately $12 million.
Desert provides IT services to a customer base that primarily consists of Texas based school districts, local government entities and corporations. Services provided by Desert include IT network and communications services, network design, implementation and maintenance. Inova and Desert have been developing three RFID pilots together for schools, libraries and prisons.
Inova is also assessing additional acquisition opportunities and is targeting businesses that offer RFID solutions or can assist Inova to enhance its current suite of RFID solutions or can accelerate the roll out of Inova RFID solutions.
(b)Exhibits*.
Exhibit No. Item
1 Press Release.
* Pursuant to Item 601(b)(2) of Regulation S-K, certain of the exhibits and schedules may have been omitted. If so, such exhibits and schedules will be provided to the Securities and Exchange Commission upon request.
What do you guys think the chance is of getting a PR with some contract details tomorrow or Friday?
I'm thinking better than 50-50 based on the following excerpt from the PR:
"With the finalization of the merger, AQUAGOLD is now one step closer to becoming a fully reporting public company, as shipments of our premium spring water continue to arrive in China. Now we are able to begin releasing details of our contracts and recent material events to the investment community."
John
Uplist to the OTCBB today! Wonder if we'll see a PR?